Biodesix, Inc.

US$8.53As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BDSXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (42.89%)
Div yield —
ROE (778.89%)
Diagnostics & Research
Beta (5Y) 0.63
PE TTM —
TSR TTM 24.89%
Mkt cap US$90.00M
ROIC (16.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$10
22.96%
(35.25%)
Hold 2|6|3|6|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.15
0.16
0.15
0.16
1.41%
7.26%
4.92%
1.79%
Revenue$M
10.96
11.57
11.25
11.27
5.23%
4.90%
3.15%
1.36%
Peers (US$90.00M)
Cap (US$)
PE
140.7M
—
33.33M
—
104.2M
19.41x
Capital
TTM
5Y
10Y
Leveragex
0.257
—
—
EBIT/Intx
0.397
0.057
0.066
Own earn%
15.83
177.06
150.35
Sh yield%
33.32
35.15
34.54
Owners
Insiders/Inst%
4.59
34.78
Short interest%
1.12
SBC / revenue%
0.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
10–18
$1 testx
—
Incr. ROIC%
1